Analysis of 754 cases of antithyroid drug-Induced agranulocytosis over 30 years in japan

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4776-4783

  Nakamura, Hirotoshi ^a   Miyauchi, Akira ^a   Miyawaki, Natsuko ^b   Imagawa, Junichi ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b Nihonbashi Muromachi 2 Chome   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CELL COUNT; CHILD; DISEASE SEVERITY; FEMALE; GRANULOCYTE; GRAVES DISEASE; HOSPITAL; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICIAN; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; VERY ELDERLY; YOUNG ADULT;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGRANULOCYTOSIS; ANEMIA, APLASTIC; ANTITHYROID AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GRAVES DISEASE; HOSPITALS, URBAN; HUMANS; INCIDENCE; JAPAN; LEUKOPOIESIS; MALE; METHIMAZOLE; MIDDLE AGED; PANCYTOPENIA; PHARMACOVIGILANCE; PROPYLTHIOURACIL; SEX DISTRIBUTION;

EID: 84889847766     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2569     Document Type: Article

References (18)

1. Cooper DS. 2013 Treatment of thyrotoxicosis. In: Braverman LE, Cooper DS, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 10th ed. Lippincott, Williams & Wilkins; 2013: 492-516
2. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905-917
3. Brent GA. Clinical practice. Graves' disease. N Engl J Med. 2008; 358:2594-2605
4. Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012;379:1155- 1166
5. Bahn Chair RS, Burch HB, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21:593-646
6. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid druginduced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med. 1990;150:621-624
7. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med. 1983;98:26-29
8. Dai WX, Zhang JD, Zhan SW, et al. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Endocr J. 2002;49:29-33.
9. Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf). 2004; 61:589-594
10. Guffy MM, Goeken NE, Burns CP. Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. Arch Intern Med. 1984;144:1687-1688
11. Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH. Agranulocytosis induced by propylthiouracil: Evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol. 1986;64:363-373
12. Bilezikian SB, Laleli Y, Tsan MF, Hodkinson BA, Ice S, McIntyre PA. Immunological: Reactions involving leukocytes. 3. Agranulo-cytosis induced by antithyroid drugs. Johns Hopkins Med J. 1976; 138:124-129
13. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: A possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab. 1984;58: 868-872
14. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab. 2007;92:2157-2162
15. Takata K, Kubota S, Fukata S, et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid. 2009; 19:559-563
16. Japan Thyroid Association Guidelines for the Treatment of Graves' Disease in Japan [Japanese]. Tokyo, Japan: Nankodo; 2011
17. Hazell L, Shakir SA. Under-reporting of adverse drug reactions : A systematic review. Drug Saf. 2006;29:385-396
18. Yamada T, Watanabe Y, Kusama M, Sugiyama Y, Ono S. Factors associated with spontaneous reporting of adverse drug reactions in Japan. Pharmacoepidemiol Drug Saf. 2013;22:468-476